Tresam Capital

Private Equity Fund | Capital Management

[Cassava Sciences @CassavaSciences]

For those of you not able to hear my talk at AAIC, here is a great write-up of the simufilam data on Seeking Alpha. With all the caveats of an open-label study,
$SAVA
#ENDAlz

https://t.co/LzwL6z0yX1

[Cassava Sciences @CassavaSciences]

Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer’s Disease
$SAVA #ENDALZ #AAIC2021

https://t.co/qobJiwaARf

[Cassava Sciences @CassavaSciences]

Cassava Sciences Announces Positive Biomarker Data with Simufilam in Alzheimer’s Disease

https://t.co/UCGh4LdzWI

$SAVA #ENDALZ #AAIC2021

[Cassava Sciences @CassavaSciences]

On Thursday, July 29th, at approximately 11 am ET, simufilam will be featured in a live podium presentation at AAIC

Watch and Listen Live to :
Lindsay H. Burns PhD - Sr. VP, Neuroscience

Share encouraging 9month Simufilam data
$SAVA #AAIC2021

[Cassava Sciences @CassavaSciences]

Looking forward seeing you at #AAIC21 !
$SAVA @alzassociation

-On Monday, July 26th, New Clinical Data for SavaDx to be Shared in
a Poster presentation

- On Thursday, July 29th, Encouraging new Clinical Data for Simufilam to be Featured in a Podium Presentation

[Cassava Sciences @CassavaSciences]

Looking forward for you to Tune in next week for our Podium Presentation.

The Alzheimer’s Association International Conference (AAIC) is the largest and most influential international meeting dedicated to advancing dementia science.
@alzassociation $SAVA #ENDALZ I

[Seeking Alpha @SeekingAlpha]

$SAVA - Cassava Sciences Is On The Brink Of Making Medical History. https://t.co/YOEjl2NT6a #finance #trading #investing

[Cassava Sciences @CassavaSciences]

The National Institutes of Health (NIH) continues to provide our research programs with substantial scientific and financial support.  Academics and scientific and medical advisors supply us with substantial technical support
#ENDAlz $SAVA

[Tresam Capital @TresamC]

Cassava to release further analysis of Alzheimer's drug simufilam in July | Seeking Alpha $SAVA https://t.co/E2qhDnjS61

[Tresam Capital @TresamC]

Cassava initiated with a buy and $110 PT at Jones Trading | Seeking Alpha $SAVA https://t.co/LxGillpgrt

[Tresam Capital @TresamC]

@StockDweebs Suggest to take a look at $SAVA Their drug for Alzheimer is very promising and the company is still very undervalued. This will be the best treatment for Alzheimer of all time no doubt now we’ve seen $LLYS last results.

[WSJ Markets @WSJmarkets]

Heard on the Street: It’s hard to find a real estate market around the world that isn’t booming https://t.co/3d11uFyohk

[Tresam Capital @TresamC]

Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam | Cassava Sciences, Inc. $SAVA https://t.co/GWeiPWzq70

[Tresam Capital @TresamC]

@StockDweebs Any comments on $SAVA ? Notice you mention $LLY which I asume you are expecting a move up due to next PR on Alzheimer treatment. Thanks !

[Tresam Capital @TresamC]

$SAVA Cassava Sciences: Early To Market In Alzheimer's (NASDAQ:SAVA) | Seeking Alpha https://t.co/AOvP9EgAoF

[Tresam Capital @TresamC]

All this $CCIV $NIO EV fever doesn’t make that much sense. What does the market expect Ford $F or $GM that have been around for 100+ years do? Just sit and watch? They will come. Crazy valuations if you put thing into perspective.

[Tresam Capital @TresamC]

$SAVA very interesting interview with Cassava Sciences CEO. Sumifilam (Alzheimer Drug) is huge. Very undervalued by the market to this day. Huge growth potential https://t.co/HsUNhgpHBy

[Tresam Capital @TresamC]

@StockDweebs Take a look at $SAVA. Very interesting company with potential novel treatment for Alzheimer and very much undervalued and under the radar for most of the market. Might be once in a lifetime investment opportunity.

[Tresam Capital @TresamC]

@TheLioncom $SAVA Great news last week just not good timing because of general market sell off. Also tomorrow CEO Remi Barbier having an interview with https://t.co/yeFG7zqd5W expecting some action and more people getting aware of the tremendous potential of Simufilam.

[Tresam Capital @TresamC]

@biggercapital Hi Michael, what is your opinion on $SAVA. (Cassava Sciences). On course for phase 3 with a novel treatment for Alzheimer with very promising results to date. Thank you